selected scholarly activity
-
academic article
- Recommendations for medical care in the pediatric oncology camp setting: Consensus statements based on Delphi methodology. Pediatric Blood and Cancer Medical and Pediatric Oncology. 67:e28107. 2020
- Severely bothersome fatigue in children and adolescents with cancer and hematopoietic stem cell transplant recipients. Supportive Care in Cancer. 27:2665-2671. 2019
- Taste changes in children with cancer and hematopoietic stem cell transplant recipients. Supportive Care in Cancer. 27:2247-2254. 2019
- Classification of the acute emetogenicity of chemotherapy in pediatric patients: A clinical practice guideline. Pediatric Blood and Cancer Medical and Pediatric Oncology. 66:e27646-e27646. 2019
- Validation of the Proxy Version of Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments. Journal of Pain and Symptom Management. 56:107-112. 2018
- Validation of the Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments. Journal of the National Cancer Institute. 110:661-668. 2018
- Working while unwell: Workplace impairment in people with severe asthma. Clinical and Experimental Allergy. 48:650-662. 2018
- Describing symptoms using the Symptom Screening in Pediatrics Tool in hospitalized children with cancer and hematopoietic stem cell transplant recipients. Cancer Medicine. 7:1750-1755. 2018
- Pediatric oncology clinical trial participation where the geography is vast: Development of a clinical research system for tertiary and satellite centers in Ontario, Canada. Pediatric Blood and Cancer Medical and Pediatric Oncology. 65:e26901-e26901. 2018
- Evaluation of the electronic self-report Symptom Screening in Pediatrics Tool (SSPedi). BMJ Supportive and Palliative Care. 8:110-116. 2018
- Treatment-related mortality in newly diagnosed pediatric cancer: a population-based analysis. Cancer Medicine. 7:707-715. 2018
- Olanzapine for prevention of chemotherapy-induced nausea and vomiting in children and adolescents: a multi-center, feasibility study. Supportive Care in Cancer. 26:549-555. 2018
- Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: A focused update. Pediatric Blood and Cancer Medical and Pediatric Oncology. 64:e26542-e26542. 2017
- Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation. BMJ Supportive and Palliative Care. 7:7-16. 2017
- Evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis. British Journal of Cancer. 116:540-545. 2017
- Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy-Induced Nausea and Vomiting in Children With Cancer. Pediatric Blood and Cancer Medical and Pediatric Oncology. 63:1144-1151. 2016
- Methodological issues identified during cognitive interviews in the development of a pediatric cancer symptom screening tool. Psycho-Oncology. 25:349-353. 2016
- Lack of treatment-related mortality definitions in clinical trials of children, adolescents and young adults with lymphomas, solid tumors and brain tumors: a systematic review. BMC Cancer. 14:612. 2014
- Refinement of the Symptom Screening in Pediatrics Tool (SSPedi). British Journal of Cancer. 111:1262-1268. 2014
- Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients. Pediatric Blood and Cancer Medical and Pediatric Oncology. 61:1506-1512. 2014
- Initial development of the Symptom Screening in Pediatrics Tool (SSPedi). Supportive Care in Cancer. 22:71-75. 2014
- Prediction of Area under the Cyclosporine Concentration Versus Time Curve in Children Undergoing Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 19:418-423. 2013
- Do children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy?. BMC Cancer. 12:314. 2012
-
conference paper
- Performance of an E-Health Decision-Support Tool for Identifying Cancer Predisposition Syndromes in Canadian Pediatric Oncology Centres. Pediatric Blood and Cancer Medical and Pediatric Oncology. S72-S73. 2019
- Olanzapine for Chemotherapy-Induced Nausea and Vomiting (CINV) Prophylaxis in Children: A Multi-Centre Feasibility Study. Pediatric Blood and Cancer Medical and Pediatric Oncology. S278-S278. 2016
- LACK OF TREATMENT-RELATED MORTALITY DEFINITIONS IN STUDIES OF CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH LYMPHOMAS, SOLID TUMORS AND BRAIN TUMORS: A SYSTEMATIC REVIEW. Pediatric Blood and Cancer Medical and Pediatric Oncology. S403-S403. 2014
- PREDICTORS OF CANCER DIAGNOSTIC INTERVALS AND ASSOCIATIONS WITH OUTCOME IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: A POPULATION-BASED COHORT STUDY USING HEALTH SERVICES DATA. Pediatric Blood and Cancer Medical and Pediatric Oncology. S81-S81. 2014
- INITIAL DEVELOPMENT OF THE SYMPTOM SCREENING IN PEDIATRIC TOOL (SSPEDI). Pediatric Blood and Cancer Medical and Pediatric Oncology. 169-169. 2013
- PEDIATRIC ONCOLOGY GROUP OF ONTARIO (POGO) GUIDELINES FOR PREVENTION OF ANTINEOPLASTIC-INDUCED NAUSEA AND VOMITING (AINV) IN CHILDREN: ACUTE AND ANTICIPATORY AINV. Pediatric Blood and Cancer Medical and Pediatric Oncology. 27-27. 2013